<- Go Home
eXoZymes, Inc.
eXoZymes, Inc. a development stage company focused on building a technology platform that can develop assets that can be reapplied multiple times in different markets with only small changes, while maintaining and capturing new fundamental IP in the application. The company produces chemicals, including pharmaceuticals, fuels, materials, food additives, colors, fragrance and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. The company was founded in 2014 and is headquartered in Monrovia, California.
Market Cap
$104.9M
Volume
29.7K
Cash and Equivalents
N/A
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$23.99
52 Week Low
$8.50
Dividend
N/A
Price / Book Value
11.81
Price / Earnings
-13.26
Price / Tangible Book Value
11.81
Enterprise Value
$97.7M
Enterprise Value / EBITDA
-15.70
Operating Income
N/A
Return on Equity
175.83%
Return on Assets
-55.33
Cash and Short Term Investments
N/A
Debt
N/A
Equity
N/A
Revenue
N/A
Unlevered FCF
N/A
Sector
Biotechnology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium